Journal
CURRENT PAIN AND HEADACHE REPORTS
Volume 20, Issue 1, Pages -Publisher
SPRINGER
DOI: 10.1007/s11916-015-0531-y
Keywords
Chronic daily headache; Chronic migraine; Inpatient; Medication overuse
Categories
Funding
- Ministry of Science and Technology of Taiwan [104-2314-B-010-015-MY2, 103-2321-B-010-017-, 103-2314-B-418-009]
- Taipei-Veterans General Hospital [VGHUST104-G7-1-1, V104C-082, V104E9-001]
- National Central University, Taiwan [MOST 103-2911-I-008-001]
- Ministry of Science and Technology support for Center for Dynamical Bio-markers and Translational Medicine
- Brain Research Center
- National Yang-Ming University
- Ministry of Health and Welfare [MOHW104-TDU-B-211-113-003]
- Far Eastern Memorial Hospital [FEMH-2015-C-017]
- Ministry of Education, Aim for the Top University Plan
Ask authors/readers for more resources
Chronic daily headache (CDH) is a group of headache disorders, in which headaches occur daily or near-daily (>15 days per month) and last for more than 3 months. Important CDH subtypes include chronic migraine, chronic tension-type headache, hemicrania continua, and new daily persistent headache. Other headaches with shorter durations (<4 h/day) are usually not included in CDH. Common comorbidities of CDH are medication overuse headache and various psychiatric disorders, such as depression and anxiety. Indications of inpatient treatment for CDH patients include poor responses to outpatient management, need for detoxification for overuse of specific medications (particularly opioids and barbiturates), and severe psychiatric comorbidities. Inpatient treatment usually involves stopping acute pain, preventing future attacks, and detoxifying medication overuse if present. Multidisciplinary integrated care that includes medical staff from different disciplines (e.g., psychiatry, clinical psychology, and physical therapy) has been recommended. The outcomes of inpatient treatment are satisfactory in terms of decreasing headache intensity or frequency, withdrawal from medication overuse, reducing disability, and improving life quality, although long-term relapse is not uncommon. In conclusion, inpatient treatment may be useful for select patients with refractory CDH and should be incorporated in a holistic headache care program.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available